Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301K Buy
856
+4
+0.5% +$1.43K 0.2% 36
2025
Q4
$279K Buy
852
+3
+0.4% +$952 0.18% 38
2025
Q3
$240K Buy
849
+4
+0.5% +$1.16K 0.16% 41
2025
Q2
$236K Buy
845
+3
+0.4% +$850 0.17% 38
2025
Q1
$262K Buy
842
+3
+0.4% +$886 0.21% 30
2024
Q4
$219K Buy
839
+4
+0.5% +$1.19K 0.17% 37
2024
Q3
$269K Buy
+835
New +$273K 0.21% 30

Other funds holding AMGN

Gordian Advisors's AMGN Position: Q1 2026 in Review

Gordian Advisors increased its Amgen (AMGN) stake by 0.47% in Q1 2026, buying an estimated $1.43K and bringing the position to 856 shares worth $301K. The position accounts for 0.2% of the portfolio, ranked #36.

Gordian Advisors first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Gordian Advisors held 856 shares of Amgen worth $301K as of Q1 2026.
  • Gordian Advisors bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.2% of Gordian Advisors's portfolio in Q1 2026, its #36 holding.
  • Gordian Advisors first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Gordian Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.